Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,055,296 papers from all fields of science
Search
Sign In
Create Free Account
recurrent small cell lung cancer
Known as:
Relapsed Small Cell Lung Carcinoma
, recurrent SCLC
, lung cancer, recurrent small cell
Expand
The reemergence of small cell carcinoma of the lung after a period of remission.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
23 relations
Bronchi
Chest
Endocrine system
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
Atlanta Ga Emory Clinic
2019
Corpus ID: 219273021
2015
2015
Efficacy of platinum rechallenge chemotherapy in sensitive relapsed small cell lung cancer after a long-term treatment-free interval.
Y. Murakami
,
H. Saka
,
M. Oki
,
C. Kitagawa
,
Y. Kogure
2015
Corpus ID: 146017045
e18554 Background: Sensitive relapsed small cell lung cancer (SCLC) is generally defined by a treatment-free interval (TFI ≧ 90…
Expand
2012
2012
Combined chemotherapy of taxotere and cisplatin in the treatment of relapsed small cell lung cancer
Qiu Bo
2012
Corpus ID: 76162266
The objective of this study was to evaluate the efficacy and safety of the taxotere combination with cisplatin regimen in…
Expand
2008
2008
Paclitaxel (P) plus bevacizumab (B) in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): A safety, feasibility and efficacy trial from the Hoosier Oncology Group
S. Jalal
,
S. Bhatia
,
+7 authors
N. Hanna
2008
Corpus ID: 68961089
2008
2008
Phase II trial of weekly topotecan with docetaxel in recurrent small cell lung cancer (Aultman Lung 01)
R. Khan
,
B. Hahn
2008
Corpus ID: 79400138
19111 Background: Small cell lung cancer constitutes up to 15% of 170,000 new lung cancer cases diagnosed each year. Patients…
Expand
2007
2007
Pemetrexed (P) in relapsed small cell lung cancer (SCLC): Preliminary results of a phase II trial
R. Raju
,
M. Neubauer
,
+7 authors
M. Socinski
2007
Corpus ID: 74264562
7716 Background: Pts with relapsed SCLC have a poor prognosis and few effective treatment options. P is a novel multitargeted…
Expand
2006
2006
Recurrent Small Cell Lung Cancer Presenting with Acute Renal Failure
Shwu-Jiuan Chen
,
Y. Wen
,
Yu Yang
,
Chia-Chu Chang
,
Meilee L Chen
2006
Corpus ID: 74668764
Acute renal failure (ARF) secondary to extensive renal parenchymal infiltration by tumor cells is extremely rare. We report a 64…
Expand
1995
1995
Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Einhorn Lh
,
Loehrer Pj
1995
Corpus ID: 221953274
: Significant advances have been made in the treatment of small cell lung cancer (SCLC) during the past two decades. Major and…
Expand
1984
1984
Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
N. Niederle
,
J. Schütte
,
C. Schmidt
,
S. Seeber
Cancer treatment reports
1984
Corpus ID: 38154017
Thirty-two males with recurrent small cell lung cancer after previous remission were treated with vindesine (3-4 mg/m2) plus…
Expand
1982
1982
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
E. Poplin
,
J. Aisner
,
D. V. Van Echo
,
M. Whitacre
,
P. Wiernik
Cancer treatment reports
1982
Corpus ID: 32658827
Thirty-two patients with refractory relapsed small cell carcinoma of the lung (SCCL) were treated with a combination of CCNU…
Expand